-
News
-
2026-10-29
STG320 (for House Dust Mite-induced Allergic Rhinitis)：Dosing of First Patient in REACH Phase III Trial
-
2026-10-23
Milestone in Beijing: Peking University Third Hospital issued the region's first prescription of Ensifentrine
-
2026-09-18
Nuance Pharma Hosts National Investigators' Meeting in Shanghai for the STG320 (Actair®) Phase III Clinical Study (REACH Study)
- 1
Contact PR
